Diseases, Conditions, Syndromes

Adding a P2Y12 inhibitor does not improve outcomes in COVID-19

(HealthDay)—The addition of a P2Y12 inhibitor to anticoagulant therapy does not improve organ support-free days among non-critically ill patients hospitalized for COVID-19, according to a study published in the Jan. 18 ...

Medications

Outpatient anticoagulant therapy may cut COVID-19 admission risk

(HealthDay)—Individuals using anticoagulation therapy on an outpatient basis who are diagnosed with COVID-19 have a reduced risk for hospital admission, according to a study published online Sept. 24 in EClinicalMedicine.

Cardiology

Lower thromboembolic risk with new A-fib after CABG versus NVAF

(HealthDay)—For patients post coronary artery bypass graft (CABG) surgery, new-onset postoperative atrial fibrillation (POAF) is associated with lower long-term thromboembolic risk than that seen among patients with nonvalvular ...

page 1 from 7